When was SmartHealth founded?

SmartHealth was founded in 1979 and raised its 1st funding round 44 years after it was founded.

Where is SmartHealth located?

SmartHealth is headquartered in Irvine, United States.

Who is the current CEO of SmartHealth?

Matthew Nunez and Larry Dentice s of SmartHealth.

How many employees does SmartHealth have?

As of Sep 30, 2026, the latest employee count at SmartHealth is 11.

Is SmartHealth a funded company?

SmartHealth is a funded company, having raised a total of $17.3M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Mar 24, 2023.

When was the latest funding round of SmartHealth?

SmartHealth's latest funding was a $***** Series B round on Nov 15, 2024, with participation from 0 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $6.58B in funding in 2026 to date.

Where does SmartHealth rank among its competitors?

SmartHealth ranks 42nd amongst 645 active competitors, of which 158 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Guardant Health, which secured $350M in Nov, 2025.

Who are the top competitors of SmartHealth?

SmartHealth's top competitors include Guardant Health, Natera and BillionToOne. Among them, Guardant Health secured the most recent funding round in November, 2025.

SmartHealth - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer precision diagnostics for vascular, metabolic, and oncological diseases. The company offer SmartPath Dx and SmartVascular Dx for diagnosing vascular inflammation and pathology. Other products include SmartLung Dx and SmartKidney Dx to detect lung cancer and kidney diseases.

Website: smarthealthdx.com
Social
Email ID: *****@smarthealthdx.com
Phone Number: +1 **********

Key Metrics

Founded Year

1979

Location

Irvine, United States

Stage

Series B

Total Funding

$17.3M in 3 rounds

Latest Funding Round

Series B, Nov 15, 2024, $*****

Ranked

42^nd among 645 active competitors

Employee Count

11 as on Sep 30, 2026

Similar Companies

Guardant Health & 776 more

View SmartHealth's full profile

SmartHealth has raised a total funding of $17.3M over 3 rounds. Its first funding round was on Mar 24, 2023.

Here is the list of recent funding rounds of SmartHealth:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 15, 2024	8434779	Series B	9859343	2907323	9229932	3831079
Aug 14, 2024	7520859	Series B	2849568	3113874	4029498	5642748
Mar 24, 2023	2211709	Series B	2617644	8375070	4345492	6274600

Access funding benchmarks and valuations. Sign up today!

View details of SmartHealth's funding rounds and investors

SmartHealth's employee count trend

SmartHealth has 11 employees as of Sep 26. Here is SmartHealth's employee count trend over the years:

Uncover SmartHealth's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SmartHealth include Guardant Health, Natera and BillionToOne. Here is the list of Top 10 competitors of SmartHealth, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Lightspeed Venture Partners ... & 25 others	80/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Bain Capital Life Sciences ... & 18 others	79/100
3rd	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	71/100
4th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	67/100
5th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Redmile Group, Deerfield & 11 others	66/100
6th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	66/100
7th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Apis Partners, Beyond Ventures & 22 others	65/100
8th	Exagen 2002, Vista (United States), Public	Developer of diagnosis, prognosis and monitoring solutions for autoimmune connective diseases	$110M	HIG BioHealth Partners, Tullis Health Investors ... & 10 others	65/100
9th	NeoGenomics 2002, Fort Myers (United States), Public	Provider of cancer genetic diagnostic services	-	Ranger Investments, Aspen Capital & 1 others	65/100
10th	Saga Diagnostics 2016, Morrisville (United States), Acquired	Provider of tests for detection and analysis of circulating tumor DNA	$17.9M	Hadean Ventures, Segulah Medical Acceleration ... & 12 others	65/100
42nd	SmartHealth 1979, Irvine (United States), Series B	Developer precision diagnostics for vascular, metabolic, and oncological diseases	$17.3M	-	50/100